Association of TLR4 (D299G, T399I), TLR9 -1486T>C, TIRAP S180L and TNF-α promoter (-1031, -863, -857) polymorphisms with risk for systemic lupus erythematosus among South Indians

Lupus

Volumn 24, Issue 1, 2015, Pages 50-57

  Rupasree, Y ^a   Naushad, S M ^b   Rajasekhar, L ^a   Uma, A ^c   Kutala, V K ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b SASTRA UNIVERSITY   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

autoantibodies; polymorphisms; Systemic lupus erythematosus; TIR domain containing adaptor protein; Toll like receptors

Indexed keywords

AUTOANTIBODY; HLA DR ANTIGEN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1 RECEPTOR; MEMBRANE PROTEIN; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TIRAP PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR;

ALOPECIA; ANTIBODY PRODUCTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MULTIFACTOR DIMENSIONALITY REDUCTION; PHENOTYPE; PHOTOSENSITIVITY; PROMOTER REGION; PSYCHOSIS; PULMONARY HYPERTENSION; RASH; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; GENETICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALOPECIA; CASE-CONTROL STUDIES; GENE EXPRESSION; HAPLOTYPES; HUMANS; HYPERTENSION, PULMONARY; INDIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; MULTIFACTOR DIMENSIONALITY REDUCTION; NUCLEAR PROTEINS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PSYCHOTIC DISORDERS; RECEPTORS, INTERLEUKIN-1; RISK FACTORS; SEIZURES; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84918504015     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314549792     Document Type: Article

References (33)

1. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A. 2000 ; 97: 13766-13771
2. Nishiya T, DeFranco AL. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J Biol Chem. 2004 ; 279: 19008-19017
3. Horng T, Barton GM, Flavell RA, Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 2002 ; 420: 329-333
4. Doyle S, Vaidya S, O'Connell R, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 2002 ; 17: 251-263
5. Schoenemeyer A, Barnes BJ, Mancl ME, et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem. 2005 ; 280: 17005-17012
6. Costa-Mattioli M, Sonenberg N. RAPping production of type I interferon in pDCs through mTOR. Nat Immunol. 2008 ; 9: 1097-1099
7. García-Bermúdez M, López-Mejías R, González-Juanatey C, et al. Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA Cell Biol. 2012 ; 31: 1214-1220
8. Sánchez E, Orozco G, López-Nevot MA, Jiménez-Alonso J, Martín J. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens. 2004 ; 63: 54-57
9. Bogaczewicz A, Sobow T, Bogaczewicz J, et al. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population - a preliminary report. Lupus. 2013 ; 22: 1504-1508
10. Hur JW, Shin HD, Park BL, Kim LH, Kim SY, Bae SC. Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens. 2005 ; 65: 266-270
11. Ramachandran R, Sharma V, Rathi M, et al. Association between -1486 T>C and +1174 G>A single nucleotide polymorphisms in TLR9 gene and severity of lupus nephritis. Indian J Nephrol. 2012 ; 22: 125-129
12. Tao K, Fujii M, Tsukumo S, et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007 ; 66: 905-909
13. Huang CM, Huang PH, Chen CL, et al. Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan. Rheumatol Int. 2012 ; 32: 2105-2109
14. Khor CC, Chapman SJ, Vannberg FO, et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet. 2007 ; 39: 523-528
15. Castiblanco J, Varela DC, Castaño-Rodríguez N, Rojas-Villarraga A, Hincapié ME, Anaya JM. TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect Genet Evol. 2008 ; 8: 541-544
16. Kirchner M, Sonnenschein A, Schoofs S, Schmidtke P, Umlauf VN, Mannhardt-Laakmann W. Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosus. Pediatr Rheumatol Online J. 2013 ; 11: 9-9
17. Jermendy A, Korner A, Kovacs M, et al. Association between toll-like receptor polymorphisms and serum levels of tumor necrosis factor-alpha and its soluble receptors in obese children. Med Sci Monit. 2010 ; 16: CR180 - CR185
18. McHugh NJ, Owen P, Cox B, Dunphy J, Welsh K. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann Rheum Dis. 2006 ; 65: 488-494
19. Rupasree Y, Naushad SM, Rajasekhar L, Kutala VK. Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: Association with serological markers and six functional polymorphisms of one-carbon metabolic pathway. Gene. 2014 ; 536: 45-52
20. Rupasree Y, Naushad SM, Rajasekhar L, Kutala VK. Association of genetic variants of xenobiotic metabolic pathway with systemic lupus erythematosus. Indian J Biochem Biophys. 2013 ; 50: 447-452
21. Yamakawa N, Ohto U, Akashi-Takamura S, et al. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A. Int Immunol. 2013 ; 25: 45-52
22. Raychaudhuri B, Bonfield TL, Malur A, et al. Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clin Immunol. 2002 ; 104: 191-198
23. Yang Z, Liang Y, Qin B, Li C, Zhong R. TLR9 polymorphisms and systemic lupus erythematosus risk in Asians: A meta-analysis study. Cytokine. 2012 ; 57: 282-289
24. Panda AK, Pattanaik SS, Tripathy R, Das BK. TLR-9 promoter polymorphisms (T-1237C and T-1486C) are not associated with systemic lupus erythematosus: A case control study and meta-analysis. Hum Immunol. 2013 ; 74: 1672-1678
25. Figueroa L, Xiong Y, Song C, Piao W, Vogel SN, Medvedev AE. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol. 2012 ; 188: 4506-4515
26. Lee KW, Lee Y, Kim DS, Kwon HJ. Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression. Eur J Immunol. 2006 ; 36: 1254-1266
27. Clancy RM, Alvarez D, Komissarova E, Barrat FJ, Swartz J, Buyon JP. Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: A novel pathway to autoimmune-associated heart block. J Immunol. 2010 ; 184: 2148-2155
28. Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol. 2007 ; 37: 2205-2213
29. Chauhan SK, Singh VV, Rai R, Rai M, Rai G. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J Clin Immunol. 2013 ; 33: 954-964
30. Yang ZH, Dai Q, Gu YJ, Guo QX, Gong L. Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma. Cancer Sci. 2012 ; 103: 653-658
31. Tsao JT, Hsieh SC, Chiang BL, Yu CL, Lin SC. Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation. Clin Exp Med. 2012 ; 12: 153-158
32. Norata GD, Garlaschelli K, Ongari M, et al. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med. 2005 ; 258: 21-27
33. Soyfoo MS, Roth J, Vogl T, Pochet R, Decaux G. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 2190-2194